Nuformix PLC - ESG Rating & Company Profile powered by AI
If you are employed by Nuformix PLC and you would like to licence your ESG rating, please get in touch. Alternative companies in the rating industry group for Nuformix PLC are displayedin the table. The assessment of Nuformix PLC is assembled by All Street Sevva using advanced machine learning.
Nuformix PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 5.3 and governance score of 5.3.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
744 | Sopharma AD | 5.0 | High |
744 | vTv Therapeutics Inc | 5.0 | High |
764 | Nuformix PLC | 4.9 | High |
764 | BetterLife Pharma Inc | 4.9 | High |
764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Nuformix PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Nuformix PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Nuformix PLC report the average age of the workforce?
Sign up for free to unlockDoes Nuformix PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Nuformix PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Nuformix PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Nuformix PLC offer flexible work?
Sign up for free to unlockDoes Nuformix PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Nuformix PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Nuformix PLC conduct supply chain audits?
Sign up for free to unlockDoes Nuformix PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Nuformix PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Nuformix PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Nuformix PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Nuformix PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Nuformix PLC disclose water use targets?
Sign up for free to unlockDoes Nuformix PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Nuformix PLC have a product recall in the last two years?
Sign up for free to unlockDoes Nuformix PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Nuformix PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Nuformix PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Nuformix PLC disclose parental leave metrics?
Sign up for free to unlockDoes Nuformix PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Nuformix PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Nuformix PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Nuformix PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Nuformix PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Nuformix PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Nuformix PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Nuformix PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Nuformix PLC disclose its waste policy?
Sign up for free to unlockDoes Nuformix PLC report according to TCFD requirements?
Sign up for free to unlockDoes Nuformix PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Nuformix PLC disclose energy use targets?
Sign up for free to unlockDoes Nuformix PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Nuformix PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Nuformix PLC
These potential risks are based on the size, segment and geographies of the company.
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.